A Frost & Sullivan White Paper

Faster Time to Market: Approaches to Biometrics for Emerging Biopharma Companies

Emerging Biopharma Companies (EBPs) are driving the growth of global clinical trials, creating a rising demand for advanced biometrics solutions to manage complex, data-intensive clinical development activities.

Download our Complimentary White Paper

Emerging Biopharma Companies (EBPs) are dominating the global clinical trial landscape, with clinical trial starts growing nearly 200% from 2011-2021. As EBPs often face resource constraints, they increasingly rely on CROs for clinical development, fueling significant growth in the CRO services market. The rise in trial complexity, use of real-world data, and stricter regulatory requirements are driving the need for advanced biometrics solutions to ensure high-quality, standardised data for successful regulatory submissions.

R

EBPs play an increasingly important role in biopharma R&D:

EBPs now represent 95% of all companies with active pipelines and 72% of all drugs in the development pipeline.

R

The volume and complexity of data from clinical trials are sharply increasing:

Data volume per trial has increased three-fold over recent years.

R

EBPs have a range of options for managing biometrics:

Outsourcing biometrics to external CROs minimises the risk of data errors/issues and maximises efficiency.

R

Key factors when choosing a CRO:

EBPs prefer to work with specialist biometrics services providers, hoping to build strong, long-term partnerships.

Download White Paper Now

Download White Paper Now

"*" indicates required fields

Comments

This field is for validation purposes and should be left unchanged.

Name*

Job Title*

Company*

Phone*

Business Email*

Country*

City*

Company Size*

This white paper is co-hosted in partnership with Frost & Sullivan, Bioforum, and Cytel. As a result, Bioforum, Cytel, and Frost & Sullivan are collecting your personal data when you submit such information as part of the registration process above. For more information on each party’s privacy practices, please see: Bioforum Privacy Notice | Cytel Privacy Notice | Frost & Sullivan Privacy Notice.

CAPTCHA

60 YEARS OF INSIGHTS

Our Global Initiatives



Empower innovation, echoing the voices of emerging technologies and companies, shaping progressive pathways in a dynamic market.



Growth Opportunity content distribution to offer a one-stop platform providing a 360-degree global perspective on the latest industry developments, events, and advancements.



Partner to equip your company with insights and enable capitalization on growth opportunities, ensuring your queries are addressed in a global marketplace.

Download White Paper Now

ABOUT THE ANALYST

Mark Dougan

A highly experienced marketing and strategy consultant with 20 years experience in Europe, Asia and Australia. I have undertaken business management, business development, project management and project delivery roles for blue-chip consulting companies.

About Our Firm

Frost & Sullivan

Frost & Sullivan has partnered with clients for more than 60 years, developing growth strategies centered on innovation, disruptive technologies, emerging markets, Mega Trends, and new business models.